Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) today announced that it has entered into an exclusive distributor and license agreement with Metuchen Pharmaceuticals LLC(“Metuchen”), a privately-held specialty pharmaceutical company dedicated to improving men’s health, granting Acerus the exclusive rights to commercialize STENDRA® in Canada.
The Design Review Panel is an independent body to guide and provide input into Tororonto Community Housing's Revitalization initiatives throughout the City of Toronto.